Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase23 Jun 2026Frontier IP Group PLCFIPP:LSEShaun ClaydonExecutive Director,Chief Financial Officer and Company Secretary41,6660.12
GBP
5.00k GBP
Purchase23 Jun 2026Verici DX PLCVRCI:LSEJulian Huw BainesNon-Executive Director,Chairman2,857,1440.0035
GBP
10.00k GBP
Purchase23 Jun 2026Verici DX PLCVRCI:LSEIan James CarruthersNon-Executive Director,Senior Independent Non-Executive Director2,857,1440.0035
GBP
10.00k GBP
Purchase23 Jun 2026Verici DX PLCVRCI:LSESara Jane BarringtonExecutive Director,Chief Executive Officer4,285,7150.0035
GBP
15.00k GBP
Purchase23 Jun 2026Verici DX PLCVRCI:LSELorenzo Giovanni GallonNon-Executive Director2,857,1440.0035
GBP
10.00k GBP
Sale23 Jun 2026Crown Holdings IncCCK:NYQTimothy J. DonahueChairman of the Board, President and Chief Executive Officer15,000105.00
USD
1.58m USD
Purchase23 Jun 2026Telecom Plus PLCTEP:LSECharles Francis WigoderNon-Executive Director,Chairman500,0007.10
GBP
3.55m GBP
Purchase23 Jun 2026Telecom Plus PLCTEP:LSENicholas SchoenfeldExecutive Director,Chief Financial Officer27,9737.08
GBP
198.02k GBP
Purchase23 Jun 2026Telecom Plus PLCTEP:LSEStuart BurnettExecutive Director,Chief Executive Officer22,3737.03
GBP
157.20k GBP
Purchase23 Jun 2026Telecom Plus PLCTEP:LSEStuart BurnettExecutive Director,Chief Executive Officer5,2287.04
GBP
36.80k GBP
Purchase23 Jun 2026Telecom Plus PLCTEP:LSEStuart BurnettExecutive Director,Chief Executive Officer22,1847.04
GBP
156.21k GBP
Sale22 Jun 2026Guidewire Software IncGWRE:NYQMichael RosenbaumChief Executive Officer and Director1,200105.67
USD
126.80k USD
Sale22 Jun 2026Palo Alto Networks IncPANW:NSQAparna BawaIndependent Director345290.17
USD
100.11k USD
Sale22 Jun 20264D Molecular Therapeutics IncFDMT:NSQDavid KirnPresident, Director and Chief Executive Officer114,74610.47
USD
1.20m USD
Sale22 Jun 2026Kymera Therapeutics IncKYMR:NMQBruce BoothChairman of the Board14,92192.14
USD
1.37m USD
24018 total results
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.